Abstract
Although one third of the world’s population is infected with Mycobacterium tuberculosis (MTB), only 5 to 10% has a lifetime risk of developing active disease. Tuberculosis can develop either within 1-2 years after infection (primary tuberculosis) or at a later date (postprimary tuberculosis). Disease localization, severity, and outcome are highly variable. For example, miliary tuberculosis, characterized by the haematogenous dissemination of large numbers of mycobacteria throughout the body, is the most serious type of disease manifestation. In contrast, tuberculous pleuritis is usually a self-limiting disease. Tuberculosis may develop anywhere in the body, but usually presents as a pulmonary infection, ranging from mild infiltration to chronic, cavitary and severely destructive disease. The different manifestations of infection with MTB reflect the balance between bacillus and host-defence mechanisms, in which the quality of host defence determines the outcome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Altare, F., Ensser, A., Breiman, A., Reichenbach, J., Baghdadi, J.E., Fischer, A., Emile, J.F., Gaillard JL, Meinl, E., and Casanova, J.L., 2001, Interleukin-12 receptor beta- 1-deficiency in a patient with abdominal tuberculosis. J. Infect.Dis. 184: 231–236.
Bellamy, R., Ruwende, C., Corrah, T., McAdam, K.P., Whittle, H.C., and Hill, V., 1998, Variations in the NRAMPI gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 338: 640–644.
Blackwell, J.M., Searle, S., Goswami, T., and Miller, E.N., 2000, Understanding the multiple functions of Nrampl. Microbes Infect. 2: 317–321.
Cervino, A.C., Lakiss, S., Sow, O., and Hill, A.V., 2000, Allelic association between the NRAMPI gene and susceptibility to tuberculosis in Guinea-Conakry. Ann. Hum. Genet. 64: 507–512.
Garred, P., Richter, C., Andersen, A.B., Madsen, H.O., Mtoni, I., Svejgaard, A., and Shao, J.,1997, Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand. J. Immunol. 46: 204–208.
Hirsch, C.S., Toossi, Z., Othieno, C., Johnson, J.L., Schwander, S.K., Robertson, S., Allis, R.S., Edmonds, K., Okwera, A., Mugerwa, R., Peters, P., and Ellner, J.J., 1999, Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 180: 2069–2073.
Keane, J., Gershon, S., Wise, R.P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W.D., Siegel, J.N., and Braun, M.M., 2001, Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345: 1098–1104.
Ottenhoff, T.H.M., Kumararatne, D., and Casanova, J.L., 1998, Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Immunol Today 19: 491–494.
Selvaraj, P., Narayanan, P.R., and Reetha, A.M., 1999, Association of functional mutant homozygotes of the mannose binding protein gene with susceptibility to pulmonary tuberculosis in India. Tuber. Lung Dis. 79: 221–227.
Stenger, S. and Modlin, R.L., 1999, T cell mediated immunity to Mycobacterium tuberculosis. Curr. Opin. Microbiol. 2: 89–93.
Wilkinson, R.J., Patel, P., Llewelyn, M., Hirsch, C.S., Pasvol, G, Snounou, G., Davidson, R.N., and Toossi, Z., 1999, Influence of polymorphism in the genes for the interleukin (IL)- 1 receptor antagonist and IL-lbeta on tuberculosis. J. Exp. Med. 189: 1863–1874.
Wilkinson, R.J., Llewelyn, M., Toossi, Z., Patel, P., Pasvol, G., Lalvani, A., Wright, D., Latif, M., and Davidson, R.N., 2000, Influence of vitamin D deficiency and Vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 355: 618–621.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
van Crevel, R., Ottenhoff, T.H.M., van der Meer, J.W.M. (2003). Innate Immunity to Mycobacterium Tuberculosis . In: Marzuki, S., Verhoef, J., Snippe, H. (eds) Tropical Diseases. Advances in Experimental Medicine and Biology, vol 531. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0059-9_20
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0059-9_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4905-1
Online ISBN: 978-1-4615-0059-9
eBook Packages: Springer Book Archive